Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples

Cancer Research
Mark BloomstonTimothy J Yeatman

Abstract

Detection of serum markers for pancreatic cancer has been elusive. Although CA 19-9 is most commonly used, its sensitivity and specificity are modest. We used large-scale proteomics to identify potential serum markers for pancreatic cancer. Samples were analyzed using high-resolution two-dimensional gel electrophoresis to identify differentially expressed proteins in 32 normal and 30 pancreatic cancer patients. Up to 1,744 protein spots were resolved for each serum sample. Candidate proteins were identified using mass spectrometry. ANOVA was used to identify proteins that could discriminate cancer from normal sera. Serum fibrinogen level was also measured using enzymatic assay. Immunohistochemistry was used to detect fibrinogen in resected pancreatic cancers. One hundred fifty-four proteins were commonly overexpressed in all pancreatic cancers. Nine protein spots (four with identifications by mass spectrometry) could effectively separate cancer from normal controls using cross-validation. These proteins successfully discriminated all pancreatic cancer samples (30 of 30) and 94% of normal (30 of 32) samples. Prominent among these candidates was fibrinogen gamma, which was subsequently confirmed to be overexpressed in pancreatic ...Continue Reading

References

Jan 1, 1991·Advances in Cancer Research·J PöllänenA Vaheri
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J A HatzfeldJ Maigne
Sep 1, 1994·CA: a Cancer Journal for Clinicians·M M MurrJ A van Heerden
Apr 8, 1999·Journal of Clinical Pathology·J M Radhi, B E Lukie
Feb 4, 2003·Nature Reviews. Drug Discovery·Gary L Glish, Richard W Vachet
Mar 1, 2003·Nature Genetics·Scott D Patterson, Ruedi H Aebersold
Mar 14, 2003·Nature·Eric PhizickyStanley Fields
Apr 3, 2003·Nature Reviews. Cancer·Julia D WulfkuhleEmanuel F Petricoin
Jan 22, 2005·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Dec 24, 2008·Digestive Diseases and Sciences·Ying LinRobert R Schade
Mar 5, 2009·Nature Clinical Practice. Gastroenterology & Hepatology·Ken HerrmannMatthias P A Ebert
Nov 10, 2006·Nature Reviews. Cancer·Emanuel F PetricoinLance A Liotta
Sep 1, 2007·Current Opinion in Gastroenterology·Tobias Grote, Craig D Logsdon
Apr 26, 2008·Pancreas·Ilona GräntzdörfferChristoph Röcken
Jan 3, 2009·BMC Bioinformatics·Shuangge Ma, Jian Huang
Nov 1, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Yantian FangChangyi Chen
Apr 18, 2008·PLoS Medicine·Kimberly A KellyRalph Weissleder
Jun 4, 2008·Upsala Journal of Medical Sciences·Gabriel SandblomIb Christian Rasmussen
Aug 3, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Shu-Hong Sheng, Hui-Li Zhu
Aug 9, 2013·Pathology Oncology Research : POR·Ilambarthi LokamaniRahman Jamal
Oct 8, 2009·The Journal of Membrane Biology·J P Lopes de AlmeidaC Saldanha
Feb 13, 2013·International Journal of Proteomics·Alessandra TessitoreEdoardo Alesse
Jun 18, 2010·European Journal of Gastroenterology & Hepatology·Douglas G WardPhilip J Johnson
Jun 12, 2010·Expert Review of Proteomics·Oxana TrifonovaAlexander Archakov
Sep 1, 2007·Expert Opinion on Medical Diagnostics·Vitor Faca, Samir Hanash
Apr 5, 2007·Molecular Cancer·William C S Cho
Feb 14, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Duygu Ozel-DemiralpNejat Akar
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lyndsay HarrisUNKNOWN American Society of Clinical Oncology
Jan 27, 2015·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Franscois RunauAshley Dennison
Mar 18, 2009·Medicinal Research Reviews·Shan JinBinghe Wang
Sep 23, 2006·Proteomics·Gilbert S Omenn
Sep 1, 2007·Proteomics. Clinical Applications·Mark Aspinall-O'Dea, Eithne Costello
Jul 18, 2008·Proteomics. Clinical Applications·Ru ChenTeresa A Brentnall
Jun 27, 2018·EMBO Molecular Medicine·Andrea ResoviRaffaella Giavazzi
Jan 14, 2011·Proteomics·Daniela CecconiMassimo Donadelli
Mar 18, 2015·Proteomics·Sheng PanRu Chen
Jan 1, 2010·Science China. Chemistry·YunFeng ChengBingHe Wang
Jun 27, 2020·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Matilda HolmCaj Haglund

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.